SARAJEVO (Bosnia and Herzegovina), January 15 (SeeNews) â Luxembourg-based Haden failed to sell its 15.95% stake in Bosnian drug maker Bosnalijek [SAJ:BSNLR] at an extraordinary auction on January 15 as the shares attracted no buyers, the Sarajevo Stock Exchange (SASE) said.